Answers are grounded in this paper and cite their sources.
Aging and age-associated disease are a major medical and societal burden in need of effective treatments. Cellular reprogramming is a biological process capable of modulating cell fate and cellular age. Harnessing the rejuvenating benefits without altering cell identity via partial cellular reprogramming has emerged as a novel translational strategy with therapeutic potential and strong commercial interests. Here, we explore the aging-related benefits of partial cellular reprogramming while examining limitations and future directions for the field.
No takes yet. Share an insight, caveat, or question.
Paine et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: